Efecto del diagnóstico precoz | 03 SEP 12

Diagnóstico de diabetes

La identificación de los pacientes con diabetes o prediabetes mediante el cribado permite una intervención precoz, aunque todavía falta establecer criterios definitivos sobre los métodos de detección.
50
33
Autor: Dr. Silvio E. Inzucchi N Engl J Med 2012;367:542-50.
INDICE:  1. Artículo | 2. Referencias
Referencias

Referencias

1. Centers for Disease Control and Prevention. 2011 national diabetes fact sheet (http://www.cdc.gov/diabetes/pubs/ factsheet11.htm).
2. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. [Erratum, Lancet 1999;354:602.]
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J. Glucose control and cardiovascular disease in type-2 diabetes. Ann Intern Med 2009;151:394-403.
5. Diabetes Prevention Program Research Group. Reduction in the incidence  of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
6. Tuomilehto J, Lindstr.m J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
7. American Diabetes Association. Standards of medical care in diabetes — 2012. Diabetes Care 2012;35:Suppl 1:S11-S63.
8. Department of Veterans Affairs/Department of Defense. Management of diabetes mellitus in primary care (2010) (http://www.healthquality.va.gov/diabetes_mellitus.asp).
9. U.S. Preventive Services Task Force. Screening for Type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:846-55. [Erratum, Ann Intern Med 2008;149:147.]
10. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
12. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
13. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
14. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-23.
15. Hanas R, John G, International HBA1c Consensus Committee. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2010;33:1903-4.
16. Nathan DM, Balkau B, Bonora E, et al. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
17. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care 2011;34:518-23.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:Suppl 1:S62-S69. [Erratum, Diabetes Care 2010;33(4):e57.]
19. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation (http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/index.html).
20. Zhang X, Gregg EW, Williamson DF, et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010;33:1665-73.
21. Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved? Clin Chem 2003;49:1245-7.
22. Freedman BI, Shihabi ZK, Andries L, et al. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 2010;31:375-9.
23. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004;112:126-8.
24. Khera PK, Joiner CH, Carruthers A, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-52.
25. Sacks DB, Nathan DM, Lachin JM. Gaps in the glycation gap hypothesis. Clin Chem 2011;57:150-2.
26. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a crosssectional analysis of 2 studies. Ann Intern Med 2010;152:770-7.
27. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community based data. Ann Intern Med 2011;154:303-9.
28. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010;33:95-7.
29. Lipska KJ, De Rekeneire N, Van Ness PH, et al. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab 2010;95:5289-95.
30. J.rgensen ME, Bjerregaard P, Borch-Johnsen K, Witte D. New diagnostic criteria for diabetes: is the change from glucose to HbA1c possible in all populations? J Clin Endocrinol Metab 2010;95(1):E333-E336.
31. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010;33:2184-9.
32. James C, Bullard KM, Rolka DB, et al. Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 2011;34:387-91.
33. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010;33:2190-5.
34. Bloomgarden ZT, Einhorn D. Hemoglobin A1c in diabetes diagnosis: time for caution. Endocr Pract 2010;16:5-6.
35. Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab 2010; 95:5203-6.
36. Davidson MB. Diagnosing diabetes with glucose criteria: worshipping a false God. Diabetes Care 2011;34:524-6.
37. Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010;47:231-6.
38. Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011;34:84-9.
39. Fajans SS, Herman WH, Oral EA. Insufficient sensitivity of hemoglobin A1c determination in diagnosis or screening of early diabetic states. Metabolism 2011;60:86-91.
40. Heianza Y, Hara S, Arase Y, et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011;378:147-55.
41. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-9.
42. DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care 2001;34:Suppl 2:S202-S209.
43. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
44. Kolberg JA, J.rgensen T, Gerwien RW, et al. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009;32:1207-12.
45. Salomaa V, Havulinna A, Saarela O, et al. Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 2010;5(4):e10100.
46. Herman WH. The economics of diabetes prevention. Med Clin North Am 011;95:373-84.
47. American Association of Clinical Endocrinologists   Board of Directors, American College of Endocrinologists Board of Trustees. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010;16:155-6.
48. Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med 2012;366:1319-27.
49. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79.
50. Taylor EN, Hu FB, Curhan GC. Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 2006;29:1065-70.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

 
Los más...
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2017